Home | Publications | Biotechnology place holder
place holder place holder

Biotechnology

Bioinformatics Markets

Strategies, Business Models and Trends for the Future

Publication Date   June 2006
Publisher   TriMark Publications
Product Type   Report
Pages   181
ISBN Number   TMRBIF06-0614
Product Code   TRI002
Ask a question about this product?

Price £1,690.00

approximately: $3,158 | €2,143

Summary


The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. believes that many of the segments of bioinformatics described in this report offer an unusual opportunity for accelerated expansion within the coming years. This study is arranged to provide an overview of bioinformatics market segments and offer evidence that these segments are poised for significant future growth. Each segment is accompanied by analysis and forecasts by product type and application. This analysis surveys the bioinformatics market and the latest information regarding emerging new products and industry trends. The study will quantify and qualify the bioinformatics market segments as an area of research, product development and investment. Forecasts of the bioinformatics market and an analysis of products in the worldwide information-processing market will provide a basis for understanding the significance of past developments and future possibilities within this market category.

Content


  • 1. Overview
    • 1.1 Statement of Report
    • 1.2 Objectives of this Report
    • 1.3 Scope of this Report
    • 1.4 Methodology
  • 2. Introduction
    • 2.1 Global Bioinformatics Products Industry
    • 2.2 Computers and Biology
      • 2.2.1 Bioinformatics and the Internet
    • 2.3 Company Evaluation Overview
    • 2.4 Market Outlook
      • 2.4.1 Competitive Structure
    • 2.5 Applications of Bioinformatics
      • 2.5.1 Healthcare
        • 2.5.2.1 Allocation of R&D
        • 2.5.2.2 Traditional Drug Discovery Process
        • 2.5.2.3 Drug Discovery and Informatics
        • 2.5.2.4 Collaborative Agreements
    • 2.6 The Human Genome Project (HGP)
      • 2.6.1 Goals of the Human Genome Project
      • 2.6.2 Benefits of the Human Genome Project
    • 2.7 Barriers to Entry
    • 2.8 Proteomics and Databases
      • 2.8.1 Protein Database Standards
      • 2.8.2 Future Trends
  • 3. The U.S. Bioinformatics Market
    • 3.1 Overview
    • 3.2 Market Revenue and Growth Forecasts
    • 3.3 Market Drivers
  • 4. Genomics
    • 4.1 The Biotechnology Industry
    • 4.2 The Development of a Genomics Market
      • 4.2.1 Market Drivers
      • 4.2.2 Market Restraints
      • 4.2.3 Market Size and Growth Projections
      • 4.2.4 The U.S. Genomics Market
    • 4.3 Biochips and Microarrays
      • 4.3.1 Key Challenges
      • 4.3.2 Freeware
      • 4.3.3 New Tools
    • 4.4 Bioinformatics
    • 4.5 Disease Targets
    • 4.6 Functional Genomics
    • 4.7 Gene Sequencing
    • 4.8 Gene Sequence Variation Detection
    • 4.9 Comparative Genomics
    • 4.10 Genome Database Arrays
    • 4.11 High-throughput Genomics
      • 4.11.1 High-throughput Technology
      • 4.11.2 Lab on a Chip
    • 4.12 Pharmacogenomics
    • 4.13 Probe Arrays
      • 4.13.1 Gene Expression Monitoring Arrays
    • 4.14 DNA Analysis Arrays
    • 4.15 Proteomics
    • 4.16 Sequencing
    • 4.17 Single Nucleotide Polymorphisms (SNPs)
    • 4.18 Structural Genomics
    • 4.19 Photolithography
    • 4.20 Instrumentation
  • 5. The Bioinformatics Industry
    • 5.1 Definition and Role of Bioinformatics
      • 5.1.1 Bioinformatics Sector Overview
      • 5.1.2 The Future Status of Bioinformatics
      • 5.1.3 Barriers to Growth
    • 5.2 Types of Data and Bioinformatics Applications
      • 5.2.1 Validated Core Modeling Technology
      • 5.2.2 Broad Applicability
      • 5.2.3 Data Management Compliant with Industry Standards
      • 5.2.4 Open Architecture
      • 5.2.5 Ease of Use
      • 5.2.6 Increased Access
    • 5.3 Functions of Informatics Software
      • 5.3.1 Data Management
      • 5.3.2 Data Transformation
      • 5.3.3 Data Collaboration
      • 5.3.4 Interface for Online Data Sources
    • 5.4 Target Markets for Informatics Software
    • 5.5 Steps Involved in Bringing a Drug to Market
    • 5.6 Costs Incurred in Developing a New Drug
    • 5.7 Industry Drivers and Challenges
    • 5.8 Industry Risks
    • 5.9 Products of Bioinformatics
    • 5.10 Bioinformatics Processes
    • 5.11 Informatics Tools and Functionalities
      • 5.11.1 Sequence to Structure
      • 5.11.2 Lead Identification and Optimization
      • 5.11.3 Development and Formulation
      • 5.11.4 Improving Materials and Processes
      • 5.11.5 Other Materials-based Industries
    • 5.12 Role of Bioinformatics in the Biotechnology Value Chain
    • 5.13 Bioinformatics Market Segments
      • 5.13.1 Databases
      • 5.13.2 Hardware
      • 5.13.3 Software
      • 5.13.4 Bioinformatics Services
    • 5.14 Bioinformatics Market Size
      • 5.14.1 Sales and R&D
      • 5.14.2 IT Budget
      • 5.14.3 Projected Bioinformatics Market Size
      • 5.14.4 Bioinformatics Market Components
    • 5.15 Bioinformatics Business Models
      • 5.15.1 Changing Business Models
      • 5.15.2 Competition for Pure Play Informatics Companies
      • 5.15.3 Non-Profit Organizations
      • 5.15.4 In-House Bioinformatics Solutions
      • 5.15.5 Large IT Companies
    • 5.16 Bioinformatics Target Disciplines
      • 5.16.1 Comparative Genomics
      • 5.16.2 Pharmacogenomics
      • 5.16.3 Functional Genomics
      • 5.16.4 Proteomics
      • 5.16.5 Structural Genomics
      • 5.16.6 Image Informatics
      • 5.16.7 Clinical Trial Informatics
      • 5.16.8 Cheminformatics
    • 5.17 Bioinformatics Architecture
    • 5.18 Bioinformatics Applications
      • 5.18.1 Data Search Tools
      • 5.18.2 Data Visualization Tools
      • 5.18.3 Data Mining and Clustering
      • 5.18.4 Enterprise Solutions
      • 5.18.5 Data Warehousing
    • 5.19 Evaluation of Bioinformatics Solutions
      • 5.19.1 Requirements of Study
      • 5.19.2 Shortlisting the Options
      • 5.19.3 Scoring Patterns
      • 5.19.4 Performance
      • 5.19.5 Data Storage
      • 5.19.6 Data Management in Drug Discovery
      • 5.19.7 Key Issues in Bioinformatics Data Storage
    • 5.20 Convergence of Industries
    • 5.21 Proteins as a Driver
    • 5.23 Current Bioinformatics Research
    • 5.24 New Bioinformatics Modeling Algorithms
    • 5.25 3D Modeling
    • 5.26 Patenting Bioinformatics Algorithms
  • 6. Recent Industry Activity: Collaborations and Acquisitions
  • 7. Product Development and Launches
  • 8. Global Market Perspective
  • 9. Corporate Profiles
    • 9.1 Accelrys
    • 9.2 Affymetrix, Inc.
    • 9.3 Agencourt Bioscience Corporation
    • 9.4 Agilent Technologies
    • 9.5 AlgoNomics
    • 9.6 ALLEZ Software
    • 9.7 ApoCom Genomics
    • 9.8 Applied Biosystems
    • 9.9 Ariadne Genomics, Inc.
    • 9.10 Array Genetics
    • 9.11 Automated Handling Systems, Inc.
    • 9.12 Avestha Gengraine Technologies Pvt. Ltd.
    • 9.13 Bioalma
    • 9.14 Biobase GmbH
    • 9.15 BioCarta
    • 9.16 Biodatabases (AMITA Corporation)
    • 9.17 BioDiscovery, Inc.
    • 9.18 BioInformatics, LLC
    • 9.19 BioInformatics Services
    • 9.20 BioInformatics Solutions, Inc.
    • 9.21 Biomax Informatics AG
    • 9.22 Bioreason, Inc.
    • 9.23 Biosiris
    • 9.24 BioSoftSolutions
    • 9.25 Biotique Systems, Inc.
    • 9.26 BioWisdom Ltd.
    • 9.27 Bio-Xtal
    • 9.28 Cambridge Antibody Technology
    • 9.29 Cambridge BlueGnome (BlueGnome)
    • 9.30 Capital Genomix
    • 9.31 Celera Genomics
    • 9.32 Cellomics, Inc.
    • 9.33 Cellectis
    • 9.34 CeuticalSoft
    • 9.35 Chemical Computing Group
    • 9.36 Cimarron Software, Inc.
    • 9.37 CLONDIAG Chip Technologies
    • 9.38 CodonCode Corporation
    • 9.39 Cognia Corporation
    • 9.40 CompuDrug
    • 9.41 Compugen Ltd.
    • 9.42 Corimbia
    • 9.43 CSIRO Bioinformatics
    • 9.44 CuraGen Corporation
    • 9.45 CyberGene
    • 9.46 Data Unlimited International
    • 9.47 deCODE Genetics
    • 9.48 Decodon GmbH
    • 9.49 Deltagen, Inc.
    • 9.50 Digilab BioVisioN
    • 9.51 Discovery Partners International, Inc.
    • 9.52 DNA Software, Inc.
    • 9.53 DNAPrint Genomics, Inc.
    • 9.54 DNA Star, Inc.
    • 9.56 DxS Genotyping, Ltd.
    • 9.57 Electric Genetics, Pvt. Ltd.
    • 9.58 Entelos
    • 9.59 Epigenomics, AG
    • 9.60 Epitope Informatics, Ltd.
    • 9.61 e-Proteomics.net
    • 9.62 EraGen Biosciences
    • 9.63 Essential Informatics
    • 9.64 European Bioinformatics Institute (EBI) Industry Programme
    • 9.65 Evolutionary BioInformatics
    • 9.66 Genamics
    • 9.67 Genebio
    • 9.68 Gene Biotechnologies
    • 9.69 GeneData, AG
    • 9.70 Gene-IT
    • 9.71 Gene Logic, Inc.
    • 9.72 GenOdyssee, SA
    • 9.73 Genolyze
    • 9.74 Genomatica
    • 9.75 Genomics Collaborative
    • 9.76 Genomic Solutions Inc.
    • 9.77 Genomining
    • 9.78 Geospiza, Inc.
    • 9.79 Glycominds
    • 9.80 Health Discovery Corporation
    • 9.81 Hitachi Corporate Technology Group
    • 9.82 Improved Outcomes Software, Inc.
    • 9.83 INCOGEN, Inc.
    • 9.84 Incyte Corporation
    • 9.85 Informagen
    • 9.86 Inpharmatica
    • 9.87 Insightful Corporation
    • 9.88 Insilico Software
    • 9.89 Insilicos
    • 9.90 Intrexon Corporation
    • 9.91 Invenio Biosolutions
    • 9.92 Invitrogen Corporation
    • 9.93 IO Informatics
    • 9.94 Kshema Technologies Ltd.
    • 9.95 LabBook
    • 9.96 LabVantage Solutions
    • 9.97 Lifespan Biosciences
    • 9.98 Lion Bioscience, AG
    • 9.99 MathEcology LLC
    • 9.100 Matrix Science
    • 9.101 Medicel, Ltd.
    • 9.102 METabolic EXplorer
    • 9.103 Metahelix Life Sciences
    • 9.104 Metalife
    • 9.105 Monogram Biosciences, Inc.
    • 9.106 Neurome, Inc.
    • 9.107 Nonlinear Dynamics
    • 9.108 Ocimum Biosolutions
    • 9.109 OmniViz, Inc.
    • 9.110 Partek Inc.
    • 9.111 Perlegen Inc.
    • 9.112 Prokaria
    • 9.113 Quantiom Bioinformatics
    • 9.114 Relevant Software, Inc.
    • 9.115 Rosetta Inpharmatics
    • 9.116 SBI Science LLC
    • 9.117 Seascape Learning
    • 9.118 Spotfire, U.S. Headquarters
    • 9.119 Spotfire AB, European Headquarters
    • 9.120 Spotfire, Japan Headquarters
    • 9.121 Strand Life Sciences Pvt. Ltd.
    • 9.122 Sun Microsystems
    • 9.123 Syngene
    • 9.124 Tahoe Informatics
    • 9.125 3rd Millennium, Inc.
    • 9.126 Thomson Scientific
    • 9.127 TIB MOLBIOL
    • 9.128 Tripos, Inc.
    • 9.129 United Bioinformatica, Inc.
    • 9.130 VizXLabs
  • Index Of Figures
    • Figure 4.1: Global Biotechnology Industry
    • Figure 5.1: Informatics Applications along the Drug-Discovery Value Chain
    • Figure 5.2: Functions of Bioinformatics Software in Research
    • Figure 5.3: Growth of GenBank, 1982-2002
    • Figure 5.4: EMBL Database Growth, 1991-2003
    • Figure 5.5: Steps Involved in Bringing a Drug to Market
    • Figure 5.6: Analysis of the Total Costs in Developing a New Drug
    • Figure 5.7: Role of Bioinformatics in the Biotechnology Value Chain
    • Figure 5.8: Worldwide Projected Pharmaceutical Sales and R&D Expenditure, 2000-2010
    • Figure 5.9: Worldwide Projected Growth in IT Budget, 2000-2010
    • Figure 5.10: Worldwide Projected Bioinformatics Market, 2000-2010
    • Figure 5.11: Worldwide Bioinformatics Market Vendor Components, 2000-2010
    • Figure 5.12: Steps of a Proteomics Experiment
    • Figure 5.13: Bioinformatics Architecture
  • Index Of Tables
    • Table 2.1: Leading Biotechnology Companies
    • Table 2.2: Pharmaceutical R&D Expenditures by World Region, 1990-2003
    • Table 2.3: Total of Domestic U.S. R&D and R&D Abroad, Ethical Pharmaceuticals, Research-Based Pharmaceutical Companies, 1980-2003
    • Table 2.4: Global Pharmaceutical R&D Expenditures, 1993-2004
    • Table 2.5: SIB Informatics Databases
    • Table 4.1: The U.S. Biotechnology Industry Size and Revenue, 1995-2005
    • Table 4.2: Global Biotechnology Industry Major Segments
    • Table 4.3: Genomics Sector Market Size, 2001-2008
    • Table 4.4: The Biochip Array Market, 2000-2010
    • Table 4.5: Selected Competitors in the Biochip Market
    • Table 4.6: Biochip Microarray Products
    • Table 4.7: Bioinformatics Tools
    • Table 4.8: Functional Genomics Companies Building Advanced Integrated Platforms and Substantial Databases
    • Table 4.9: Companies Using New Genomic Tools
    • Table 4.10: Non-DNA Based Chip Suppliers
    • Table 4.11: Robotics or Lab-on-a-Chip Market Sector
    • Table 4.12: Key High-Throughput and Systemic Approaches for Genomic Analysis
    • Table 4.13: Total Biochip Market, 2002-2010
    • Table 4.14: Pharmacogenomics Segment Players
    • Table 4.15: The Worldwide Market for Pharmacogenomics, 2000-2008
    • Table 4.16: Competitors in the SNP Genotyping Segment
    • Table 4.17: Scanning and Detection Technology Suppliers
    • Table 5.1: Data Sources and Bioinformatic Investigations
    • Table 5.2: Drivers and Challenges of the Bioinformatics Industry
    • Table 5.3: Bioinformatics Activities, Sub-Activities and Key Players
    • Table 5.4: Alliances between IT/Telecom and Biotechnology Firms
    • Table 5.5: Types of Intellectual Property Protection for Bioinformatics Tools
    • Table 8.1: Bioinformatics Market Size, 2000-2010
    • Table 8.2: Cheminformatics Market Size, 2004-2010
    • Table 8.3: In-silico Informatics Market Size, 2004-2010
    • Table 8.4: Bioinformatics Hardware and Systems Market Size, 2004-2010